Midlands State University Library

Drug discovery in cancer epigenetics (Record no. 155319)

MARC details
000 -LEADER
fixed length control field 02142nam a22003137a 4500
003 - CONTROL NUMBER IDENTIFIER
control field ZW-GwMSU
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20201012153942.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201012b ||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780128022085
040 ## - CATALOGING SOURCE
Language of cataloging English
Transcribing agency MSU
Description conventions rda
245 ## - TITLE STATEMENT
Title Drug discovery in cancer epigenetics
Statement of responsibility, etc edited by Gerda Egger and Paola Arimondo
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Oxford :
Name of publisher, distributor, etc Elsevier,
Date of publication, distribution, etc 2016
300 ## - PHYSICAL DESCRIPTION
Extent 475 pages :
Other physical details ill(chiefly color)
Dimensions 25 cm
336 ## - CONTENT TYPE
Source rdacontent
content type term text
337 ## - MEDIA TYPE
source rdamedia
media type term unmediated
media type code n
338 ## - CARRIER TYPE
source rdacarrier
carrier type term volume
carrier type code nc
490 ## - SERIES STATEMENT
Series statement Translational epigenetics series
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note I. Introduction. Basic epigenetic mechanisms and phenomena -- Cancer epigenetics -- II. Methods and tools for epigenetic drug development -- Drug discovery methods -- Preclinical cancer models with the potential to predict clinical response -- Discovery of biomarkers for drug development -- Networks and consortia for epigenetic drug discovery -- III. Classes of epigenetic drugs -- DNA methyltransferase inhibitors -- Small molecule inhibitors of histone deacetylases and acetyltransferases as potential therapeutics in oncology -- Targeting histone methylation. The development of selective methyltransferase and demethylase inhibitors -- Bromodomains as anti-cancer targets -- Epigenetic readers interpreting the lysine methylome: biological roles and drug discovery -- Non coding RNAs: clinical and therapeutic applications -- IV. Clinical implications of epigenetic therapy. Clinical applications of epigenetic drugs -- Efficacy of combined epigenetic therapies -- Predicting and monitoring responses to epigenetic drugs -- Episensitization: a new word for a new concept -- The emerging potential for epigenetic therapeutics in non-cancer disorders
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Genetic aspects
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Epigenetics
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Neoplasms
General subdivision drug therapy
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Gene expression
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug development
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Neoplasms
General subdivision genetics
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Egger, Gerda
Relator term editor
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Arimondo, Paola
Relator term editor
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Full call number Barcode Date last seen Copy number Price effective from Koha item type
    Library of Congress Classification     Medical School Medical School Open Shelf 12/10/2020 Book Aid 90.00 RC268.4 DRU BK138374 12/10/2020 150701 12/10/2020 Book